
### [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637)
**Label:** familial chylomicronemia syndrome

**Subclasses:** [MONDO:0007327](http://purl.obolibrary.org/obo/MONDO_0007327) (chylomicronemia, familial, due to Circulating inhibitor of lipoprotein lipase), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein c-II deficiency), 

**Corr. equiv. classes:** [OMIM:207750](http://purl.obolibrary.org/obo/OMIM_207750), [Orphanet:309020](http://www.orpha.net/ORDO/Orphanet_309020), [OMIM:615947](http://purl.obolibrary.org/obo/OMIM_615947), [OMIM:118830](http://purl.obolibrary.org/obo/OMIM_118830), [OMIM:238600](http://purl.obolibrary.org/obo/OMIM_238600), [Orphanet:309015](http://www.orpha.net/ORDO/Orphanet_309015), 

**Class expressions from DL-Learner:**

- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 68.30%
- [HP:0000660](http://purl.obolibrary.org/obo/HP_0000660) (Lipemia retinalis) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 68.30%


